Fused pyrimidine derivatives as TRPV3 modulators
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 8, 2013
Grant Date -
Nov 18, 2010
app pub date -
Jan 7, 2009
filing date -
Jan 11, 2008
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention related to fused pyrimidine derivatives, which are useful as Transient Receptor Potential Vanilloid 3 (TRPV3) receptors, methods of treating diseases, disorders, conditions modulated by TRPV3. The present invention having the formula (I) and its pharmaceutically acceptable salts thereof, and its processes thereof, wherein all variables are as described herein.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully